Mirum Pharmaceuticals Inc (NAS:MIRM)
$ 32.05 0.91 (2.92%) Market Cap: 1.51 Bil Enterprise Value: 1.47 Bil PE Ratio: 0 PB Ratio: 6.42 GF Score: 44/100

Q2 2022 Mirum Pharmaceuticals Inc Earnings Call Transcript

Aug 04, 2022 / 08:30PM GMT
Release Date Price: $26.05 (+11.80%)
Operator

Good afternoon. My name is Chris, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Mirum Q2 2022 Business Update. (Operator Instructions)

Ian Clements, Chief Financial Officer. You may begin.

Ian Clements
Mirum Pharmaceuticals, Inc. - CFO

Thanks, Chris, and good afternoon, everyone. I'd like to welcome you to Mirum Pharmaceuticals Second Quarter 2022 Conference Call. I'm joined today by our President and CEO, Chris Peetz; our Chief Operating Officer, Peter Radovich; and our Head of R&D, Pam Vig.

Earlier this afternoon, Mirum issued a news release announcing the company's results for the second quarter of 2022. Copies of this news release from SEC filings can be found in the Investors section of our website.

Before we begin, I would like to remind you that during the course of this conference call, we will be making certain forward-looking statements about Mirum and our programs based on management's current expectations, including statements regarding Mirum's business plans,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot